
|Videos|June 12, 2015
Federal Compounding Law and Health-System Pharmacists
Chris Topoleski, director of federal regulatory affairs for ASHP discusses how the federal compounding law will affect health-system pharmacists.
Advertisement
Chris Topoleski, director of federal regulatory affairs for ASHP discusses how the federal compounding law will affect health-system pharmacists.
This video was taken at ASHP's Summer Meetings and Exposition in June 2015.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5


























